Literature DB >> 25510305

CORR Insights(®): incidence and risk factors of allograft bone failure after calcaneal lengthening.

Laura Bruse Gehrig1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25510305      PMCID： PMC4385360          DOI： 10.1007/s11999-014-4101-0

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  5 in total

1.  Talocalcaneal tarsal coalitions and the calcaneal lengthening osteotomy: the role of deformity correction.

Authors:  Vincent S Mosca; Wesley P Bevan
Journal:  J Bone Joint Surg Am       Date:  2012-09-05       Impact factor: 5.284

2.  Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy.

Authors:  Richard C Henderson; Robert K Lark; Matthew J Gurka; Gordon Worley; Ellen B Fung; Mark Conaway; Virginia A Stallings; Richard D Stevenson
Journal:  Pediatrics       Date:  2002-07       Impact factor: 7.124

3.  Predicting low bone density in children and young adults with quadriplegic cerebral palsy.

Authors:  Richard C Henderson; John Kairalla; Almas Abbas; Richard D Stevenson
Journal:  Dev Med Child Neurol       Date:  2004-06       Impact factor: 5.449

4.  Long-term outcome of planovalgus foot surgical correction in children with cerebral palsy.

Authors:  Muayad Kadhim; Laurens Holmes; Freeman Miller
Journal:  J Foot Ankle Surg       Date:  2013-07-25       Impact factor: 1.286

5.  Calcaneal lengthening for planovalgus foot deformity in patients with cerebral palsy.

Authors:  Ki Hyuk Sung; Chin Youb Chung; Kyoung Min Lee; Seung Yeol Lee; Moon Seok Park
Journal:  Clin Orthop Relat Res       Date:  2012-11-21       Impact factor: 4.176
  5 in total
  1 in total

1.  Relationship between Subtalar Joint Stiffness and Relaxed Calcaneal Stance Position in Cerebral Palsy Children with Valgus Deformities.

Authors:  Wei Chen; Jie Yao; Yang Yang; Xiaoyu Liu; Lizhen Wang; Fang Pu; Yubo Fan
Journal:  Biomed Res Int       Date:  2018-04-30       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.